Drug Approval | August 31, 2023
Unichem receives ANDA approval for Prasugrel Tablets
Prasugrel tablets are indicated to reduce the rate of thrombotic CV events
Prasugrel tablets are indicated to reduce the rate of thrombotic CV events
Mankind Pharma's initiative aims to ensure universal access to medicines of international calibre
In Phase I studies, ZYIL1 was found to be safe and well-tolerated in human volunteers
The company is committed to address the observations and will submit its response to US FDA within the stipulated time
The drug will be manufactured at JB Pharma's formulation manufacturing facility in Panoli, Gujarat
Eris Lifesciences enters into term loan agreement with Citi Bank
Oteseconazole Capsules were found to be safe and more effective than fluconazole
Aurobindo's product is already filed with the Drugs Controller General of India (DCGI) and is expected to be approved soon
Deep Transcranial Magnetic Stimulation (dTMS) is a non-invasive brain stimulation technique approved by regulatory authorities, including the USFDA
Senvelgo is the first liquid once-daily, orally administered prescription medication to improve glycemic control in cats with diabetes mellitus
Subscribe To Our Newsletter & Stay Updated
